|
A Randomized Phase III Study of Sublobar Resection versus Sublobar
Resection plus Brachytherapy in High Risk Patients with Non-Small
Cell Lung Cancer (NSCLC) 3 cm. or smaller
Part I: Pre-Operative Criteria: Patients must have
a suspicious lung nodule for clinical Stage I NSCLC; Must have
a mass 3 cm or less maximum diameter by CT size estimate, clinical
Stage IA or selected Stage IB.; Must have CT scan of chest with
upper abdomen within 60 days prior to pre-registration; ECOG/Zubrod
Performance Status 0, 1, 2; Must meet at least one major criteria
or two minor criteria; Must not have had previous intrathoracic
radiation therapy; Women of child bearing potential must have negative
pregnancy test; Patients must provide a signed and dated informed
consent prior to registration and any study related procedures
being performed.
Part II: Intra-Operative Criteria: Patients must have
biopsy-proven NSCLC; Must have all suspicious mediastinal lymph
nodes assessed to confirm negative involvement with NSCLC.
*Please see protocol for full details of eligibility
criteria.
<< Back to Clinical
Trials Main Page >>
[ top ] |
